Vendiz Pharmaceuticals
Vendiz Pharmaceuticals Inc. is a 100% Filipino-owned pharmaceutical distribution company founded in 1990, distributing approximately 17 OTC and prescription products across ophthalmology, otology, dermatology, and supplements to healthcare providers and patients in the Philippines through its cGMP-certified manufacturing partner Ashford.
- Company typePrivate
- Founded1990
- HeadquartersAntipolo, Philippines
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Vendiz Pharmaceuticals does
Vendiz Pharmaceuticals Inc. is a 100% Filipino-owned pharmaceutical distribution company founded in 1990 by Juvencio D. Dizon and headquartered in Antipolo, Rizal, Philippines. The company distributes over-the-counter and prescription pharmaceutical products across four therapeutic categories: ophthalmological preparations, otological preparations, dermatological products, anti-infective medications, and vitamin/bone health supplements. Its catalog comprises approximately 17 SKUs — including products such as Dizoflox Eye/Ear Drops, Fungtopic Cream, Sterizol Cream, Doxicon Antibiotic Capsules, and Osteoprotec Bone Food Supplement — covering both Rx and OTC segments. Manufacturing is handled through a long-standing partnership with Ashford Pharmaceuticals Laboratories Inc., a cGMP-certified local manufacturer that was acquired by Vendiz's chairman in 1991, creating vertical integration between distribution and production.
The business operates on a sales-led go-to-market model, distributing through healthcare provider networks, hospital channels, and pharmacies across the Philippines. Revenue is generated through one-time product sales of both prescription and OTC pharmaceutical products; pricing is quote-based and not publicly disclosed. The company claims an extensive distribution footprint of 540+ branches, 640+ hospital affiliations, and 238+ local partners, serving over 1 million patients cumulatively, though these figures are unverified. The 9,700 sqm manufacturing facility in Antipolo became fully operational in 1995, and corporate operations were consolidated at the Ashford compound in 2023.
Vendiz is a privately held, founder-controlled corporation with no disclosed external investors, no funding rounds, no subsidiaries, and no AI/ML technology stack. Its competitive position rests on the cGMP compliance of its manufacturing partner, three decades of brand presence in the Philippine market, and cost-effective local pricing — rather than technology differentiation or scale-based advantages. The company shows no current signals of geographic expansion beyond the Philippines, and its digital presence is minimal.
Vendiz Pharmaceuticals firmographics
Firmographics- Name
- Vendiz Pharmaceuticals
- Legal name
- Vendiz Pharmaceuticals Inc.
- Website
- https://vendizpharma.com
- Company type
- Private
- Founded year
- 1990
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Vendiz Pharmaceuticals Inc. is a 100% Filipino-owned pharmaceutical distribution company founded in 1990, distributing approximately 17 OTC and prescription products across ophthalmology, otology, dermatology, and supplements to healthcare providers and patients in the Philippines through its cGMP-certified manufacturing partner Ashford.
- Ownership category
- akta.pro rank
Vendiz Pharmaceuticals industry classification
Industry- Product category
- Pharmaceutical Distribution
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (424210), Ophthalmic Goods Merchant Wholesalers (423460)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Ophthalmic Goods (3851)
- akta.pro primary industry
- Specialty Pharmaceutical Distributors (HLAIAJAB)
- akta.pro secondary industries
- Ophthalmology Specialty Pharmaceuticals (HLAIACAK), Specialty Care Pharmaceuticals (HLAIAAAB)
Keywords
Where Vendiz Pharmaceuticals is headquartered
LocationHeadquarters
- HQ city
- Antipolo
- HQ country
- Philippines
- HQ region
- Asia
Offices2 records
Markets served
Vendiz Pharmaceuticals business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Marketing or Sales
Revenue model
- Pharmaceutical Product Sales: Vendiz Pharmaceuticals generates revenue through the sale of prescription and over-the-counter pharmaceutical products including oral medications, topical treatments, and drops for eyes, ears, skin, and bones. The company distributes both prescription drugs requiring physician authorization and OTC products available directly to consumers.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Vendiz Pharmaceuticals product offering
Product offeringCore offering
Vendiz Pharmaceuticals Inc. is a 100% Filipino-owned pharmaceutical distribution company that markets a portfolio of prescription and over-the-counter pharmaceutical products manufactured by its cGMP-certified partner Ashford Pharmaceuticals Laboratories Inc. The product range spans ophthalmological preparations, otological preparations, anti-infective medications, dermatological products, and vitamin/bone/eye food supplements.
Product overview
Vendiz Pharmaceuticals Inc. is a 100% Filipino-owned pharmaceutical distribution company established in 1990, specializing in over-the-counter (OTC) and prescription pharmaceutical products. The company partners with Ashford Pharmaceutical Laboratories Inc., a cGMP-certified manufacturer, to distribute a broad portfolio of 17 healthcare products spanning multiple therapeutic categories. The product portfolio includes: oral prescription antibiotics (Doxicon Antibiotic Capsule); ophthalmic preparations (Dizoflox Eye Drops, Maxotopic Eye Drops, Novasorin Eye Drops, Venpred Eye Drops, Hypromax Eye Drops); otological preparations (Dizoflox Ear Drops, Hydrospor Ear Drops, Otixin Ear Drops, Vendicom Ear Drops); dermatological products (B.N.P. Ointment, Fungtopic Cream, Hydrotopic Cream, Sterizol Cream, Steroderm Cream); and dietary supplements (Osteoprotec Bone Food Supplement Capsule, vitaCLEAR Eye Food Supplement Capsule). Products are categorized by type (Oral, Topical, Drops) and application area (Eyes, Ears, Skin, Bones), with both prescription and OTC options available.
Differentiator
Problem solved
Functional benefit
Products and services
- Doxicon Antibiotic Capsule Oral antibiotic capsule containing Doxycycline Hydrochloride, a tetracycline antibiotic used for treating bacterial infections. For patients prescribed by physicians.
- B.N.P. Ointment
- Dizoflox Ear Drops
- Dizoflox Eye Drops
- Fungtopic Cream
- Hydrospor Ear Drops
- Hydrotopic Cream
- Hypromax Eye Drops
- Maxotopic Eye Drops
- Novasorin Eye Drops
- Osteoprotec Bone Food Supplement Capsule
- Otixin Ear Drops
- Sterizol Cream
- Steroderm Cream
- Vendicom Ear Drops
- Venpred Eye Drops
- vitaCLEAR Eye Food Supplement Capsule
Companies that use Vendiz Pharmaceuticals
Customer profileSegments1 record
Ideal customer profiles1 record
Vendiz Pharmaceuticals technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Vendiz Pharmaceuticals partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Ashford Pharmaceuticals Laboratories Inc.coreVendiz Pharmaceuticals established a strategic partnership with Ashford Pharmaceuticals Laboratories Inc., a local manufacturer awarded with the Certificate of Current Good Manufacturing Practices (cGMP). Ashford manufactures pharmaceutical products for Vendiz, including ophthalmological preparations, otological preparations, anti-infectives, dermatological products, and vitamin supplements. The partnership began when Vendiz was organized in 1990 to market Ashford's products, and in 1991, Ashford was acquired by Mr. Juvencio D. Dizon, Chairman of Vendiz Pharmaceuticals.
Scale indicators5 records
Recent moves8 records
Expansion highlights3 records
Vendiz Pharmaceuticals competitors and assessment
Company assessmentMarket position
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Vendiz Pharmaceuticals social profiles
Digital presenceVendiz Pharmaceuticals compliance and trust
Trust signalCompliance1 record
Vendiz Pharmaceuticals financial estimates
Financial estimateRevenue estimate
Valuation estimate
Vendiz Pharmaceuticals leadership team
Management profileNumber of profiles
Profiles1 record
Vendiz Pharmaceuticals funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Vendiz Pharmaceuticals M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Vendiz Pharmaceuticals
What does Vendiz Pharmaceuticals do?
Vendiz Pharmaceuticals Inc. is a 100% Filipino-owned pharmaceutical distribution company that markets a portfolio of prescription and over-the-counter pharmaceutical products manufactured by its cGMP-certified partner Ashford Pharmaceuticals Laboratories Inc. The product range spans ophthalmological preparations, otological preparations, anti-infective medications, dermatological products, and vitamin/bone/eye food supplements.
Is Vendiz Pharmaceuticals a public or private company?
Vendiz Pharmaceuticals is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Vendiz Pharmaceuticals founded?
Vendiz Pharmaceuticals was founded in 1990. It employs 11 to 50 people.
Where is Vendiz Pharmaceuticals based?
Vendiz Pharmaceuticals is headquartered in Antipolo, Philippines, in the Asia region.
How does Vendiz Pharmaceuticals make money?
One revenue line is on record: pharmaceutical Product Sales.
Does Vendiz Pharmaceuticals have an API?
No public API is recorded for Vendiz Pharmaceuticals.
What industry is Vendiz Pharmaceuticals in?
Vendiz Pharmaceuticals's product category is Pharmaceutical Distribution. Its primary akta.pro industry code is HLAIAJAB, Specialty Pharmaceutical Distributors, with a secondary code of HLAIACAK, Ophthalmology Specialty Pharmaceuticals. Its NAICS code is 424210 and its SIC code is 5122.